Read the full Report (pdf)
American Society of Hematology
09
–12 December 2023
San Diego, CA, USA
Featured articles
EditorProf. Gert Ossenkoppele, Amsterdam UMC, the Netherlands
ConferenceASH 2023
7 February 2024 15:14
Presented ByRobert van den Heuvel, Medicom
ConferenceASH 2023
4 January 2024 10:55
ExpertProf. Jeff Sharman , The US Oncology Network and Willamette Valley Cancer Institute, Oregon, USA
TrialPhase 3, ELEVATE-TN ConferenceASH 2023
18 December 2023 18:14
Leukaemia
Presented ByProf. Alexander Perl, University of Pennsylvania, PA, USA
TrialPhase 3, QuANTUM-First ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:05
Presented ByDr Jad Othman, Royal North Shore Hospital, Australia
ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByDr Musa Yilmaz, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByDr Ibrahim Aldoss, City of Hope National Medical Center, CA, USA
TrialPhase 2, AUGMENT-101 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByProf. Martin Schrappe, Hong Kong College of Paediatricians, China
TrialPhase 3, AIEOP-BFM ALL 2017 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:02
Presented ByDr Xiaoyuan Gong, Chinese Academy of Medical Sciences, China
TrialPhase 2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:02
Presented ByDr Moritz Fürstenau, University of Cologne, Germany
TrialPhase 2, CLL2-BAAG ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:01
Lymphoma
Presented ByProf. Bertram Glass, Helios Klinikum Berlin-Buch, Germany
TrialPhase 2, ASTRAL ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:00
Presented ByDr Paolo Strati, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:00
Presented ByDr Charalambos Andreadis, University of California San Francisco, USA
TrialPhase 3, A051301/BMT-CTN 1201 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Presented ByDr Elizabeth Budde, City of Hope National Medical Center, CA, USA
TrialPhase 1/2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Presented ByProf. Michael Wang, University of Texas, TX, USA
TrialPhase 3, SYMPATICO ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Multiple Myeloma
Presented ByProf. Meletios Dimopoulos, University of Athens, Greece
TrialPhase 3, CANDOR ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:58
Presented ByProf. Francesca Gay, University of Torino, Italy
TrialPhase 3, IsKia ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:57
Presented ByProf. Pieter Sonneveld, Erasmus MC, the Netherlands
TrialPhase 3, Perseus ConferenceASH 2023
TypePeer-reviewed article
6 February 2024 16:34
Myeloproliferative Neoplasms
Presented ByProf. Naveen Pemmaraju, MD Anderson Cancer Center, TX, USA
TrialPhase 3, TRANSFORM-1 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:57
Presented ByProf. Ruben Mesa, Wake Forest Baptist Comprehensive Cancer Center, NC, USA
TrialPhase 3, Simplify-1, MOMENTUM ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:57
Presented ByDr Trine Knudsen, University Hospital Odense, Denmark
TrialPhase 3, DALIAH ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:57
Non-Malignant Haematology
Presented ByProf. Antonio Risitano, University of Naples, Italy
TrialPhase 3, APPLY-PNH ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:56
Presented ByProf. Catherine Broome, Georgetown University, DC, USA
TrialPhase 3, ADVANCE IV ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:56
Presented ByProf. Michael Tarantino, University of Illinois, IL, USA
TrialPhase 1/2, LUNA 2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:55
Presented ByDr Julie Jaffray, Rady Children’s Hospital-San Diego, CA, USA
ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:55
Miscellaneous Topics
Presented ByProf. Daniel Wolff, University Hospital Regensburg, Germany
TrialPhase 2, AGAVE-201 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:54
Presented ByProf. Keith McCrae, Cleveland Clinic, OH, USA
TrialPhase 2, PATH-HHT ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:54
Presented ByDr Sean Wen, University of Cambridge, UK
ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:54
Featured Interviews
ExpertDr Eliza Hawkes, Olivia Newton-John Cancer Wellness & Research Centre, Australia
TrialPhase 2, WAMM ConferenceASH 2023
4 January 2024 14:30
ExpertProf. Jeff Sharman , The US Oncology Network and Willamette Valley Cancer Institute, Oregon, USA
TrialPhase 3, ELEVATE-TN ConferenceASH 2023
18 December 2023 18:14